DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	TGFB1I1; SUSD5; NUAK1; DSCAM; MPDZ; CLSTN1; FN1; APP; ITGB1; ITGAV; LAMB1; THBS1; PTPRF; ITGB4; ITGA2; ITGB6; CDH2; VCAM1; CDH3; ANOS1; TNC; AZGP1; LAMA1; L1CAM; THBS2; MCAM; CD151; EFNB2; EPHB4; CDH11; BCAR1; CLDN10; SRPX; EFNB1; COL7A1; COL16A1; DDR1; MFGE8; SPOCK1; PTK7; LAMC2; COL4A6; DSG2; FAT1; POSTN; PTPRK; IGFBP7; FLG2; CERCAM; AMTN; PTPRU; FEZ1; COL12A1; OMD; FERMT1; NTM; EGFL7; CLCA2; LOXL2; PCDHAC1; PCDHB13; PCDHB2; PCDHAC2; PCDHA11; PCDHGC5; PCDHB16; ICAM5; TGFBI;	GO:0007155~cell adhesion	68	454	14.9779735682819	0	0	0	0	0	0	0
down	AGRN; LAMA5; PDGFB; COL4A1; FN1; PDGFA; APP; SERPINE1; ITGB1; COL5A2; ITGAV; LAMB1; THBS1; COL4A2; SPARC; ITGB4; ITGA2; ITGB6; VCAM1; TNC; LAMA1; ITGA3; COL4A5; FBN2; SOX9; MFAP2; HSPG2; COL7A1; COL16A1; DDR1; FOXF2; LAMB3; LAMC2; COL4A6; LAMA3; SH3PXD2A; EGFLAM; PXDN; ICAM5; NR2E1; COL27A1; MMP2; COL17A1; TGFBI; COL22A1; MMP10; MMP16; MMP14; MMP17; MMP19; POSTN;	GO:0030198~extracellular matrix organization	51	230	22.1739130434783	0	0	0	0	0	0	0
down	SNAI2; ONECUT2; PLAU; PDGFB; PDGFA; ITGB1; ITGAV; LAMB1; THBS1; IGF1R; VIL1; F3; MDK; MCAM; CD151; MMP14; CDH13; BCAR1; CAV1; LAMC2; PDPN; TWIST2; PIK3R3; HAS2; SPHK1; CCL26; PDGFC; SEMA6D; SEMA4F; SEMA3C; SEMA7A;	GO:0030335~positive regulation of cell migration	31	226	13.716814159292	0	0	0	0	0	0	0
down	CAV1; DUSP4; SPRED2; SPRED1; DUSP10; SPRED3;	GO:0000188~inactivation of MAPK activity	6	26	23.0769230769231	0.00011986752079806	0.00409261963867686	0.361640310247768	0.372428387119594	0.294689489047952	0.361640310247768	0.0352734271390416
down	THBS1; GPC1; SULF1; APLN; SPRY4;	GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway	5	16	31.25	0.0001359496862644	0.00459125733938586	0.410024253773439	0.422395675223499	0.318326514812396	0.410024253773439	0.0395710805145272
down	WT1; PKD2; SIX1; SIX4;	GO:0072075~metanephric mesenchyme development	4	8	50	0.00015883991056187	0.00530661937758849	0.478902330344038	0.49351560211573	0.351989241805104	0.478902330344038	0.0457366353327939
down	VAV2; FGD1; DAB2IP; FGD6; BVES; AJUBA; PLXNB1; PLXNB3; PLXNA1;	GO:0043087~regulation of GTPase activity	9	71	12.6760563380282	0.00016522643337735	0.00546126094152589	0.49799247019934	0.513358528503434	0.36135020979627	0.49799247019934	0.0470694584191769
down	NRP1; PTK7; CDC42BPA; SYDE1; MICALL2; ANTXR1; PARVA; PLEK2;	GO:0031532~actin cytoskeleton reorganization	8	56	14.2857142857143	0.00018107888778595	0.00592223267737862	0.545590688899089	0.562612104350969	0.380759114172674	0.545590688899089	0.0510424767725306
down	WT1; FBN2; EFEMP1; MAB21L1; FOXC2; MAB21L2; LAMA1;	GO:0043010~camera-type eye development	7	42	16.6666666666667	0.00019635304836807	0.00628937032247003	0.591415381684626	0.610068921279593	0.39748650652695	0.591219028636258	0.0542067588503828
down	MMP14; DLX1; DLX2; EGFL7; JAG1; DLL1; JAG2;	GO:0045746~negative regulation of Notch signaling pathway	7	42	16.6666666666667	0.00019635304836807	0.00628937032247003	0.591415381684626	0.610068921279593	0.39748650652695	0.591219028636258	0.0542067588503828
down	GJC1; FSCN1; CDH2; CDH11; CDH3; CDH10; CDH13;	GO:0007043~cell-cell junction assembly	7	43	16.2790697674419	0.00022346226115321	0.00691928892588734	0.672621406071185	0.694297245403048	0.427259843324952	0.672621406071185	0.05963589469071
down	DLL1; TBX3; SOX9; CAV1;	GO:0030857~negative regulation of epithelial cell differentiation	4	9	44.4444444444444	0.0002249269975908	0.00691928892588734	0.676805335750723	0.698848181514622	0.428922934204257	0.676355481755541	0.05963589469071
down	FBN2; MFAP2; FOXL2; EFEMP1;	GO:0048048~embryonic eye morphogenesis	4	9	44.4444444444444	0.0002249269975908	0.00691928892588734	0.676805335750723	0.698848181514622	0.428922934204257	0.676355481755541	0.05963589469071
down	PLOD3; PXDN; LAMB3; LAMB1;	GO:0070831~basement membrane assembly	4	9	44.4444444444444	0.0002249269975908	0.00691928892588734	0.676805335750723	0.698848181514622	0.428922934204257	0.676355481755541	0.05963589469071
down	TBX1; LHX2; TCF15; EXT1; FOXC2; HES7;	GO:0007498~mesoderm development	6	30	20	0.00023677241239639	0.00721227338544693	0.711737871663551	0.735651885315587	0.439787858406938	0.711737871663551	0.0621610660722576
down	AGRN; NRP1; PLXNB1; FLNB; DIRAS1; GNA14; PLAU; POMC; IGF1R; CGB7; BMP1; MDK; NR2F2; EDNRA; AXL; GDNF; SOX9; PGF; VEGFC; VAV2; MAPK12; FGD1; PTK7; PTPRK; EXT1; ARTN; TENM4; SYDE1; ARHGAP22; RASSF8; FGF11; RASD2; DPYSL5; RTKN; TENM2; TENM3; METRN; TRHDE; APLN; CCL26; KCNIP3; DTNA; WIF1; NPR2; PDCD1LG2;	GO:0007165~signal transduction	45	989	4.55005055611729	0.00024588176395512	0.0074170353457143	0.73887470068515	0.763954640608573	0.448228309290491	0.73887470068515	0.0639258663038944
down	DLL1; ZNF536; APP; FOXG1; JAG1; DIXDC1; DISP3; NR2E1;	GO:0045665~negative regulation of neuron differentiation	8	59	13.5593220338983	0.00024995072272404	0.00746727784138088	0.750851971063034	0.776596895503611	0.451793965518728	0.750851971063034	0.0643588957976276
down	FSTL3; COL5A2; SPARC; BMP1; NPR2; SOX9; CDH11; EXT1; FOXC2;	GO:0001503~ossification	9	76	11.8421052631579	0.00026275981432588	0.00777518802962407	0.789067722420635	0.816394743110527	0.459785888287144	0.789067722420635	0.0670127088927229
down	SIX1; PROX1; SIX4;	GO:0030910~olfactory placode formation	3	3	100	0.00028757157484515	0.00835032600975613	0.863002296110319	0.893484883043906	0.475161097811277	0.863002296110319	0.071969702072681
down	HOXC11; HOXA11; GDNF; SIX1;	GO:0001759~organ induction	4	10	40	0.00030871536386201	0.00888128366221545	0.926146091586033	0.959178635519268	0.488153649214906	0.926146091586033	0.0765459143087136
down	WNT7A; ADGRB2; THBS2; AMIGO2; NLGN2; CLSTN1; FLRT3; FLRT2;	GO:0051965~positive regulation of synapse assembly	8	62	12.9032258064516	0.00033890352521348	0.00958592608144065	1	1	0.505286471676552	0.998695237800947	0.0826190789875729
down	CDH2; VCAM1; FAT4; AMIGO2; TENM2; TENM4; TENM3;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	7	47	14.8936170212766	0.00036360067047436	0.0101157746886712	1	1	0.519221757437389	0.998695237800947	0.0871857325962411
down	TBX3; TBX1; FSTL3; TFAP2A; INHBA; HOXC6; WT1; HOXA11; HOXA13; HOXC12; HOXD11; CDKN1A; TSC22D1; DMRTA2; FOXA2; KCNIP3; MAGED1; DLX2; EGR4; HMGB3; FOXC2; ZIC5; FOXL2; ETV4; TCF7L1; EN2; TCF15; HMGB1P1; NR2E1; FOXD1; ETV5; TWIST2; GLIS2; DLX1; NR2F2; SATB2;	GO:0006357~regulation of transcription by RNA polymerase II	36	747	4.81927710843374	0.00036464974738692	0.0101157746886712	1	1	0.519741491125278	0.998695237800947	0.0871857325962411
down	SOCS2; PRSS23; FSTL3; FN1; APP; LAMB1; MELTF; LGALS1; CDH2; TNC; MFGE8; FSTL1; IGFBP7; TMEM132A; NOTUM; AMTN; FAM20C; PCSK9; FBXO17; EVA1A; FBXO2;	GO:0043687~post-translational protein modification	21	344	6.1046511627907	0.00036931907535964	0.0101466043897673	1	1	0.522406447290069	0.998695237800947	0.087451447300108
down	NEFL; MAP6; METRN; PLXNB3; PLXNB1; PLXNA1;	GO:0050772~positive regulation of axonogenesis	6	33	18.1818181818182	0.00037229253312953	0.0101466043897673	1	1	0.524138539472232	0.998695237800947	0.087451447300108
down	NRP1; ITGB1; EFNB2; EPHB4; PIK3R3;	GO:0002042~cell migration involved in sprouting angiogenesis	5	21	23.8095238095238	0.00039649963850196	0.0107123858854401	1	1	0.536067511254661	0.998695237800947	0.0923277989101213
down	APP; HOXD9; HOXD10; GDNF; PREX2; DMBX1; FOXA2;	GO:0008344~adult locomotory behavior	7	48	14.5833333333333	0.00040778412991138	0.0109222869968505	1	1	0.540924930856782	0.998695237800947	0.0941368924036306
down	LAMA5; TGFB1I1; VEGFC; JAG2;	GO:0016331~morphogenesis of embryonic epithelium	4	11	36.3636363636364	0.00041271759504502	0.0109599450239733	1	1	0.543136355079247	0.998695237800947	0.0944614590121085
down	TBX1; ITGB1; SOX9; FOXA2; TBX3; TBX2;	GO:0001708~cell fate specification	6	34	17.6470588235294	0.00042886214113147	0.0112921582414871	1	1	0.550125446255929	0.998695237800947	0.0973247348005195
down	DLL1; LAMA5; NUAK1; LAMA1; SOX9; LAMA3; JAG2;	GO:0030155~regulation of cell adhesion	7	49	14.2857142857143	0.00045615280050936	0.0118105562598551	1	1	0.561980250227542	0.998695237800947	0.101792698194215
down	AGRN; LRP4; APP; ELFN1; L1CAM; NLGN2; PCDHGC5;	GO:0050808~synapse organization	7	49	14.2857142857143	0.00045615280050936	0.0118105562598551	1	1	0.561980250227542	0.998695237800947	0.101792698194215
down	MDK; LHX2; PROX1; DISP3; NR2E1;	GO:2000179~positive regulation of neural precursor cell proliferation	5	22	22.7272727272727	0.00047672075790594	0.0122410859075519	1	1	0.570158026455512	0.998695237800947	0.105503342598037
down	GDNF; SIX1; SIX4;	GO:0072107~positive regulation of ureteric bud formation	3	4	75	0.00049394582661133	0.012328360000797	1	1	0.576964842983786	0.998695237800947	0.106255539635875
down	SPRED2; SPRED1; SPRED3;	GO:0090311~regulation of protein deacetylation	3	4	75	0.00049394582661133	0.012328360000797	1	1	0.576964842983786	0.998695237800947	0.106255539635875
down	SIPA1L3; FSTL3; KRT75; INHBA; DACT2; BVES; STON2; PYGO1;	GO:0002244~hematopoietic progenitor cell differentiation	8	66	12.1212121212121	0.00049599130997735	0.012328360000797	1	1	0.577829876123613	0.998695237800947	0.106255539635875
down	TBX3; SNAI2; TFAP2A; INHBA; FOXF2; TBX2; ALX4; SATB2;	GO:0060021~roof of mouth development	8	66	12.1212121212121	0.00049599130997735	0.012328360000797	1	1	0.577829876123613	0.998695237800947	0.106255539635875
down	HIC1; SPRED2; SPRED1; SPRED3;	GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator	4	12	33.3333333333333	0.00053950498909149	0.0130956406336507	1	1	0.594324942576368	0.998695237800947	0.112868569892191
down	NRP1; PLXNB1; PLXNA1; PLXNB3;	GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance	4	12	33.3333333333333	0.00053950498909149	0.0130956406336507	1	1	0.594324942576368	0.998695237800947	0.112868569892191
down	TERT; TBX3; HMGA2; NR2E1;	GO:2000648~positive regulation of stem cell proliferation	4	12	33.3333333333333	0.00053950498909149	0.0130956406336507	1	1	0.594324942576368	0.998695237800947	0.112868569892191
down	SEMA7A; FN1; L1CAM; MAP1B; TNFRSF12A; DBN1;	GO:0045773~positive regulation of axon extension	6	36	16.6666666666667	0.00056195178478835	0.0135347612041659	1	1	0.602556589980473	0.998695237800947	0.116653257651332
down	DSCAM; TFAP2A; LHX1; SDK2; FJX1;	GO:0010842~retina layer formation	5	23	21.7391304347826	0.000568565244906	0.0135454429323804	1	1	0.60495342057999	0.998695237800947	0.11674532121823
down	TGFB1I1; TBX1; COL4A1; VIL1; WT1; FZD2; SIX1; GATA6;	GO:0030855~epithelial cell differentiation	8	68	11.7647058823529	0.00059415568032616	0.013985164384647	1	1	0.614429626236245	0.998695237800947	0.120535187850697
down	SOCS2; CLSTN1; MELTF; BCAR1; DDR1; SPOCK1; IGFBP7; PAPPA2;	GO:0001558~regulation of cell growth	8	69	11.5942028985507	0.00064880534665579	0.0150653946130393	1	1	0.634627435039169	0.998695237800947	0.129845464792754
down	PLXNB1; PDGFB; PDGFA; CSF3; SOX9; TGFB2; SERPINA12; PDGFC; IGF1R;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	9	87	10.3448275862069	0.00064974666177897	0.0150653946130393	1	1	0.635021923492352	0.998695237800947	0.129845464792754
down	TGFB2; JAG1; SOX4; SEMA3C;	GO:0003215~cardiac right ventricle morphogenesis	4	13	30.7692307692308	0.00069169142096936	0.0151344031334635	1	1	0.650589363624668	0.998695237800947	0.130440234703487
down	FN1; APP; MAPK12; CAV1;	GO:0010952~positive regulation of peptidase activity	4	13	30.7692307692308	0.00069169142096936	0.0151344031334635	1	1	0.650589363624668	0.998695237800947	0.130440234703487
down	PAX7; LHX1; LHX5; LHX3;	GO:0021527~spinal cord association neuron differentiation	4	13	30.7692307692308	0.00069169142096936	0.0151344031334635	1	1	0.650589363624668	0.998695237800947	0.130440234703487
down	DLX1; DLX2; TMEM98; DUSP10;	GO:0048715~negative regulation of oligodendrocyte differentiation	4	13	30.7692307692308	0.00069169142096936	0.0151344031334635	1	1	0.650589363624668	0.998695237800947	0.130440234703487
down	EDNRA; LHX1; MMP14; FLRT3;	GO:0060322~head development	4	13	30.7692307692308	0.00069169142096936	0.0151344031334635	1	1	0.650589363624668	0.998695237800947	0.130440234703487
down	ITGA2; CPS1; PROX1; E2F7;	GO:0070365~hepatocyte differentiation	4	13	30.7692307692308	0.00069169142096936	0.0151344031334635	1	1	0.650589363624668	0.998695237800947	0.130440234703487
down	PTK7; FZD2; CELSR1; VANGL2;	GO:0090179~planar cell polarity pathway involved in neural tube closure	4	13	30.7692307692308	0.00069169142096936	0.0151344031334635	1	1	0.650589363624668	0.998695237800947	0.130440234703487
down	WNT7A; EFNB2; NLGN4Y; NLGN2;	GO:0099054~presynapse assembly	4	13	30.7692307692308	0.00069169142096936	0.0151344031334635	1	1	0.650589363624668	0.998695237800947	0.130440234703487
down	CDH11; AKAP12; GRIK2; PLCB4; NLGN2; NTNG1; GRIN3B; NLGN4Y;	GO:0050804~modulation of chemical synaptic transmission	8	71	11.2676056338028	0.00077025561441845	0.0161755844572214	1	1	0.675081565701006	0.998695237800947	0.139413957356584
down	PLAU; PDGFA; PLXNA1;	GO:0014910~regulation of smooth muscle cell migration	3	5	60	0.00077572001420211	0.0161755844572214	1	1	0.676605273331998	0.998695237800947	0.139413957356584
down	LRP4; APP; SHANK3;	GO:0051124~synaptic growth at neuromuscular junction	3	5	60	0.00077572001420211	0.0161755844572214	1	1	0.676605273331998	0.998695237800947	0.139413957356584
down	NRP1; SEMA3C; PLXNA1;	GO:0060666~dichotomous subdivision of terminal units involved in salivary gland branching	3	5	60	0.00077572001420211	0.0161755844572214	1	1	0.676605273331998	0.998695237800947	0.139413957356584
down	PLAU; VIL1; TNFRSF12A;	GO:0061041~regulation of wound healing	3	5	60	0.00077572001420211	0.0161755844572214	1	1	0.676605273331998	0.998695237800947	0.139413957356584
down	NRP1; SIX1; SIX4;	GO:0061551~trigeminal ganglion development	3	5	60	0.00077572001420211	0.0161755844572214	1	1	0.676605273331998	0.998695237800947	0.139413957356584
down	WT1; LHX1; PKD2;	GO:0072284~metanephric S-shaped body morphogenesis	3	5	60	0.00077572001420211	0.0161755844572214	1	1	0.676605273331998	0.998695237800947	0.139413957356584
down	AGRN; SDC3; GPC4; GPC1; HSPG2;	GO:0006027~glycosaminoglycan catabolic process	5	25	20	0.00079129443532421	0.0162818000698831	1	1	0.681304259802403	0.998695237800947	0.140329407362943
down	NRP1; SEMA4F; SEMA6D; SEMA7A; SEMA3C;	GO:0048843~negative regulation of axon extension involved in axon guidance	5	25	20	0.00079129443532421	0.0162818000698831	1	1	0.681304259802403	0.998695237800947	0.140329407362943
down	FSTL3; INHBA; WT1; HOXA11; SOX9; MMP14; TGFB2; GATA6; SIX4;	GO:0008584~male gonad development	9	90	10	0.00081224923330902	0.0166030155782312	1	1	0.68711109799251	0.998695237800947	0.143097896211154
down	HOXD10; HOXA11; FBN2; TGFB2; MEGF8; HOXC10;	GO:0030326~embryonic limb morphogenesis	6	39	15.3846153846154	0.00081921234942139	0.0166359004552436	1	1	0.688957585863393	0.998695237800947	0.143381324043614
down	TGFB1I1; ONECUT2; NR2E1; WNT7A; GATA5; GATA6; WNT9A;	GO:0045165~cell fate commitment	7	55	12.7272727272727	0.00085069344023092	0.0171630163558277	1	1	0.697568620989355	0.998695237800947	0.147924425028951
down	FLT4; TCF15; CCBE1; JAG2;	GO:0003016~respiratory system process	4	14	28.5714285714286	0.00087191842870804	0.0172550990955152	1	1	0.703215193190373	0.998695237800947	0.148718066778219
down	SNAI2; EFNB2; PTPRK; CD109;	GO:0010839~negative regulation of keratinocyte proliferation	4	14	28.5714285714286	0.00087191842870804	0.0172550990955152	1	1	0.703215193190373	0.998695237800947	0.148718066778219
down	TBX1; JAG1; TBX2; SIX1;	GO:0035909~aorta morphogenesis	4	14	28.5714285714286	0.00087191842870804	0.0172550990955152	1	1	0.703215193190373	0.998695237800947	0.148718066778219
down	SNAI2; SOX9; HMGA2; TGFB2; FOXF2; LOXL2;	GO:0001837~epithelial to mesenchymal transition	6	40	15	0.000922518623508	0.017837978453668	1	1	0.716796970465721	0.998695237800947	0.153741781265721
down	ITGB1; KRT8; KRT19; TPM1; FHOD3; SIX4;	GO:0045214~sarcomere organization	6	40	15	0.000922518623508	0.017837978453668	1	1	0.716796970465721	0.998695237800947	0.153741781265721
down	APP; ITGA3; TCF7L1; VANGL2; DACT2;	GO:0030111~regulation of Wnt signaling pathway	5	26	19.2307692307692	0.0009243368300742	0.017837978453668	1	1	0.717204399053851	0.998695237800947	0.153741781265721
down	NRP1; DSCAM; APP; THBS1; APLN;	GO:0042327~positive regulation of phosphorylation	5	26	19.2307692307692	0.0009243368300742	0.017837978453668	1	1	0.717204399053851	0.998695237800947	0.153741781265721
down	SH3PXD2B; PDGFB; FN1; CSF2; APP; TFAP2A; INHBA; WT1; CDH3; TNC; ITGA3; SOX9; HMGA2; CAV1; MAPK11; FOXD1; RBMS3; PIK3R3; GATA5; C1QTNF1; IL1F10;	GO:0010628~positive regulation of gene expression	21	374	5.61497326203209	0.00101447877042604	0.0194567008624303	1	1	0.733202947953581	0.998695237800947	0.1676932089538
down	TBX1; TFAP2A; GBX2; FOXG1; SIX1; CELSR1; SIX4;	GO:0042472~inner ear morphogenesis	7	57	12.280701754386	0.00102959439056516	0.0196254587207727	1	1	0.735892138703601	0.998695237800947	0.169147697410075
down	CDH2; CDH3; CDH11; CDH13; CDH10;	GO:0044331~cell-cell adhesion mediated by cadherin	5	27	18.5185185185185	0.00107331262812194	0.0201460383172479	1	1	0.74371820595912	0.998695237800947	0.173634463366238
down	FGF5; CDH2; DNER; METRN;	GO:0010001~glial cell differentiation	4	15	26.6666666666667	0.00108284145445137	0.0201460383172479	1	1	0.745213526406091	0.998695237800947	0.173634463366238
down	RAC3; TGFB2; FOXC2; FERMT1;	GO:0033630~positive regulation of cell adhesion mediated by integrin	4	15	26.6666666666667	0.00108284145445137	0.0201460383172479	1	1	0.745213526406091	0.998695237800947	0.173634463366238
down	HOXA11; LHX1; FOXL2; TGFB2;	GO:0060065~uterus development	4	15	26.6666666666667	0.00108284145445137	0.0201460383172479	1	1	0.745213526406091	0.998695237800947	0.173634463366238
down	HOXC4; PAX7; SOX9; EVC; DLX2; SULF1; SATB2;	GO:0051216~cartilage development	7	58	12.0689655172414	0.00112947152120602	0.0202775544030253	1	1	0.753464491015273	0.998695237800947	0.174767972824444
down	SERPINE1; SERPINE2; THBS1;	GO:0010757~negative regulation of plasminogen activation	3	6	50	0.00114212166737349	0.0202775544030253	1	1	0.75595341835606	0.998695237800947	0.174767972824444
down	SOX1; GBX2; LHX6;	GO:0021884~forebrain neuron development	3	6	50	0.00114212166737349	0.0202775544030253	1	1	0.75595341835606	0.998695237800947	0.174767972824444
down	SOX9; DLX1; DLX2;	GO:0046533~negative regulation of photoreceptor cell differentiation	3	6	50	0.00114212166737349	0.0202775544030253	1	1	0.75595341835606	0.998695237800947	0.174767972824444
down	EFNB2; CCBE1; PROX1;	GO:0048845~venous blood vessel morphogenesis	3	6	50	0.00114212166737349	0.0202775544030253	1	1	0.75595341835606	0.998695237800947	0.174767972824444
down	SERPINE1; FAM20C; HTRA1;	GO:0097187~dentinogenesis	3	6	50	0.00114212166737349	0.0202775544030253	1	1	0.75595341835606	0.998695237800947	0.174767972824444
down	MMP14; SNRPN; FHL2; STEAP2; MMP19; FOXC2;	GO:0009725~response to hormone	6	42	14.2857142857143	0.00115892995968814	0.0203434767500059	1	1	0.758936304721852	0.998695237800947	0.175336143655929
down	SNAI2; SLIT3; SOX9; JAG1; GATA5;	GO:0003180~aortic valve morphogenesis	5	28	17.8571428571429	0.00123936123172674	0.0215122645082402	1	1	0.773271739389483	0.998695237800947	0.185409679305679
down	ITGB1; APOA4; VCAM1; NT5E; CERCAM;	GO:0007159~leukocyte cell-cell adhesion	5	28	17.8571428571429	0.00123936123172674	0.0215122645082402	1	1	0.773271739389483	0.998695237800947	0.185409679305679
down	CDH13; ARHGAP29; PDPN; RTKN; CELSR1; VANGL2; RAC3; RHOBTB1;	GO:0007266~Rho protein signal transduction	8	77	10.3896103896104	0.00124765471782773	0.0215359067127264	1	1	0.774765514020618	0.998695237800947	0.185613446489287
down	MMP2; MMP10; MMP14; MMP19; MMP16; MMP17;	GO:0030574~collagen catabolic process	6	43	13.953488372093	0.0012932430170709	0.0220775057914246	1	1	0.78254849866415	0.998695237800947	0.190281374937974
down	CDH2; CDH3; EFNB2; CDH11; CDH13; CDH10;	GO:0034332~adherens junction organization	6	43	13.953488372093	0.0012932430170709	0.0220775057914246	1	1	0.78254849866415	0.998695237800947	0.190281374937974
down	SIPA1L3; FLNB; FAT1; DACT2;	GO:0003382~epithelial cell morphogenesis	4	16	25	0.0013271171779331	0.0222883949829089	1	1	0.788611885421613	0.998695237800947	0.192098984485642
down	PTPRG; PFN2; DAB2IP; DUSP10;	GO:0010633~negative regulation of epithelial cell migration	4	16	25	0.0013271171779331	0.0222883949829089	1	1	0.788611885421613	0.998695237800947	0.192098984485642
down	TERT; PDGFB; DOCK7; ADAMTS1;	GO:1904754~positive regulation of vascular associated smooth muscle cell migration	4	16	25	0.0013271171779331	0.0222883949829089	1	1	0.788611885421613	0.998695237800947	0.192098984485642
down	WNT7A; NKX2-8; APP; BRSK1; NRCAM; DOCK7; NTNG1; MAP1B;	GO:0007409~axonogenesis	8	78	10.2564102564103	0.00134617484326172	0.022462084726031	1	1	0.79205598566341	0.998695237800947	0.193595979818635
down	ITGAV; WT1; GJC1; CAV1; TEAD2; HAS2; EGFL7;	GO:0001570~vasculogenesis	7	60	11.6666666666667	0.00135191819883096	0.022462084726031	1	1	0.793226474498642	0.998695237800947	0.193595979818635
down	NRP1; COL4A1; EDNRA; GBX2; FOXC2;	GO:0001569~branching involved in blood vessel morphogenesis	5	29	17.2413793103448	0.00142364137980111	0.0234034590848786	1	1	0.805635534390558	0.998695237800947	0.201709487251275
down	ITGB1; ITGAV; VCAM1; NRCAM; PARVA;	GO:0034113~heterotypic cell-cell adhesion	5	29	17.2413793103448	0.00142364137980111	0.0234034590848786	1	1	0.805635534390558	0.998695237800947	0.201709487251275
down	KRT8; INHBA; G0S2; TGFB2; MLLT11; TNFRSF12A;	GO:0097191~extrinsic apoptotic signaling pathway	6	44	13.6363636363636	0.00143912221096665	0.0235334353130178	1	1	0.80765228135391	0.998695237800947	0.202829725000649
down	TBX1; FLT4; EFNB2;	GO:0001945~lymph vessel development	3	7	42.8571428571429	0.00160155150627117	0.0252230635201447	1	1	0.82768982214498	0.998695237800947	0.217392274838637
down	PLOD2; PLOD3; P3H3;	GO:0017185~peptidyl-lysine hydroxylation	3	7	42.8571428571429	0.00160155150627117	0.0252230635201447	1	1	0.82768982214498	0.998695237800947	0.217392274838637
down	HOXD10; HOXC10; LHX3;	GO:0021520~spinal cord motor neuron cell fate specification	3	7	42.8571428571429	0.00160155150627117	0.0252230635201447	1	1	0.82768982214498	0.998695237800947	0.217392274838637
down	TGFB2; SIX1; SIX4;	GO:0048699~generation of neurons	3	7	42.8571428571429	0.00160155150627117	0.0252230635201447	1	1	0.82768982214498	0.998695237800947	0.217392274838637
down	NRP1; DSCAM; MEGF8;	GO:0048842~positive regulation of axon extension involved in axon guidance	3	7	42.8571428571429	0.00160155150627117	0.0252230635201447	1	1	0.82768982214498	0.998695237800947	0.217392274838637
down	LHX1; TENM4; FOXA2;	GO:2000543~positive regulation of gastrulation	3	7	42.8571428571429	0.00160155150627117	0.0252230635201447	1	1	0.82768982214498	0.998695237800947	0.217392274838637
down	PLAU; SERPINE1; PCSK9; HMGB1P1;	GO:0010469~regulation of signaling receptor activity	4	17	23.5294117647059	0.00160739188187597	0.0252230635201447	1	1	0.828148946720131	0.998695237800947	0.217392274838637
down	LHX1; LHX3; LAMC2; EGFLAM; AGRN;	GO:0008045~motor neuron axon guidance	5	30	16.6666666666667	0.00162732843082902	0.0252805471729289	1	1	0.830479351760672	0.998695237800947	0.217887714341249
down	NRP1; PDGFB; PDGFA; BCAR1; PDGFC;	GO:0048008~platelet-derived growth factor receptor signaling pathway	5	30	16.6666666666667	0.00162732843082902	0.0252805471729289	1	1	0.830479351760672	0.998695237800947	0.217887714341249
down	SOX9; AKAP12; MAPK11; PTGIS; DAB2IP; HAS2; ADAMTS7; CCL26;	GO:0071347~cellular response to interleukin-1	8	81	9.87654320987654	0.00167927501989318	0.0258292449841985	1	1	0.836319929393529	0.998695237800947	0.222616825271634
down	SOCS2; ATP7B; CAV1; DDR1; APLN; NCOR2;	GO:0007595~lactation	6	46	13.0434782608696	0.00176813726694469	0.0269294239627312	1	1	0.846909987738819	0.998695237800947	0.232099036291792
down	DLL1; SPARC; KCNQ1; TGFB2; SIX1; LHX3;	GO:0048839~inner ear development	6	46	13.0434782608696	0.00176813726694469	0.0269294239627312	1	1	0.846909987738819	0.998695237800947	0.232099036291792
down	THBS1; SPARC; NR2F2; CAV1; SULF1;	GO:0001937~negative regulation of endothelial cell proliferation	5	31	16.1290322580645	0.00185161165962833	0.0280632069583669	1	1	0.855744965268299	0.998695237800947	0.241870873261467
down	LHX2; DLX2; EXT1; NR2E1;	GO:0021772~olfactory bulb development	4	18	22.2222222222222	0.00192629079183859	0.028912973382814	1	1	0.862909573539165	0.998695237800947	0.249194831191657
down	ITGA2; SPHK1; ADRA1B; ADRA1D;	GO:0045987~positive regulation of smooth muscle contraction	4	18	22.2222222222222	0.00192629079183859	0.028912973382814	1	1	0.862909573539165	0.998695237800947	0.249194831191657
down	GLI2; EN2; TGFB2; TENM4; TENM3; TENM2;	GO:0048666~neuron development	6	47	12.7659574468085	0.00195258051495417	0.0291666714421279	1	1	0.864993168124698	0.998695237800947	0.251381401359565
down	TGM2; AXL; JAG1; FOXC2; SEMA3C;	GO:0001974~blood vessel remodeling	5	32	15.625	0.00209769157744955	0.0310933988809501	1	1	0.878624970152058	0.998695237800947	0.267987459564392
down	ITGAV; TPM1; ITGA2; MDK; TGM2; FRMD5;	GO:0045785~positive regulation of cell adhesion	6	48	12.5	0.00215120299546978	0.0310933988809501	1	1	0.883463090307017	0.998695237800947	0.267987459564392
down	PDGFB; FN1; PDGFA; CDKN1A; PDGFC; SPHK1;	GO:0048146~positive regulation of fibroblast proliferation	6	48	12.5	0.00215120299546978	0.0310933988809501	1	1	0.883463090307017	0.998695237800947	0.267987459564392
down	PDGFB; PDGFA; C1QTNF1;	GO:0010544~negative regulation of platelet activation	3	8	37.5	0.00216162670044584	0.0310933988809501	1	1	0.884105320482349	0.998695237800947	0.267987459564392
down	MMP2; MSX2; FBN2;	GO:0060346~bone trabecula formation	3	8	37.5	0.00216162670044584	0.0310933988809501	1	1	0.884105320482349	0.998695237800947	0.267987459564392
down	DLL1; ITGA3; JAG1;	GO:0072006~nephron development	3	8	37.5	0.00216162670044584	0.0310933988809501	1	1	0.884105320482349	0.998695237800947	0.267987459564392
down	MELTF; FSCN1; PDPN;	GO:0090091~positive regulation of extracellular matrix disassembly	3	8	37.5	0.00216162670044584	0.0310933988809501	1	1	0.884105320482349	0.998695237800947	0.267987459564392
down	GLI2; MSX2; SATB2; PTHLH;	GO:0002076~osteoblast development	4	19	21.0526315789474	0.00228640833617766	0.032736731338728	1	1	0.895987773858166	0.998695237800947	0.282150996084339
down	WNT7A; SYT1; STXBP1; STX1A; BRSK1; GAD1;	GO:0007269~neurotransmitter secretion	6	49	12.2448979591837	0.00236468285648661	0.0332741041892244	1	1	0.90323890644041	0.998695237800947	0.286782499561806
down	TPM1; DES; KCNQ1; TBX2; KCNJ12;	GO:0008016~regulation of heart contraction	5	33	15.1515151515152	0.002366777285426	0.0332741041892244	1	1	0.90323890644041	0.998695237800947	0.286782499561806
down	ITGB1; VAV2; CDH13; AJUBA; WASF3;	GO:0030032~lamellipodium assembly	5	33	15.1515151515152	0.002366777285426	0.0332741041892244	1	1	0.90323890644041	0.998695237800947	0.286782499561806
down	SOX9; DLX1; GATA6; GATA5; ADAMTS7;	GO:0071773~cellular response to BMP stimulus	5	33	15.1515151515152	0.002366777285426	0.0332741041892244	1	1	0.90323890644041	0.998695237800947	0.286782499561806
down	TGFB1I1; ONECUT2; CAV1; VEPH1; CD109; HTRA1; PMEPA1;	GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway	7	68	10.2941176470588	0.0026021540358796	0.0364184350877384	1	1	0.924662707251586	0.998695237800947	0.31388282567118
down	PDGFA; COL5A2; ITGA3; TCF15; DACT2;	GO:0043588~skin development	5	34	14.7058823529412	0.00266008386666317	0.0367328025498776	1	1	0.93021986488597	0.998695237800947	0.316592292650681
down	DSCAM; LRP4; ITGB1; PREX2; MAP6;	GO:0048813~dendrite morphogenesis	5	34	14.7058823529412	0.00266008386666317	0.0367328025498776	1	1	0.93021986488597	0.998695237800947	0.316592292650681
down	TBX3; SLIT3; TGFB2; SOX4; PROX1;	GO:0060412~ventricular septum morphogenesis	5	34	14.7058823529412	0.00266008386666317	0.0367328025498776	1	1	0.93021986488597	0.998695237800947	0.316592292650681
down	DDR1; POSTN; FLRT3; PLXNA1;	GO:1990138~neuron projection extension	4	20	20	0.0026902992735679	0.0369856630220153	1	1	0.933096511190827	0.998695237800947	0.318771643831036
down	TBX1; PDGFB; PDGFA; CDH2; ADRA1B; FLT4; DAB2IP; C1QTNF1; IGF1R;	GO:0043410~positive regulation of MAPK cascade	9	109	8.25688073394496	0.00276967088401836	0.0378569615975962	1	1	0.940079338108263	0.998695237800947	0.326281182839171
down	SERPINH1; TRAM2; P3H3;	GO:0032964~collagen biosynthetic process	3	9	33.3333333333333	0.00282922229706672	0.0378569615975962	1	1	0.945313379448493	0.998695237800947	0.326281182839171
down	FN1; COL16A1; FERMT2;	GO:0033622~integrin activation	3	9	33.3333333333333	0.00282922229706672	0.0378569615975962	1	1	0.945313379448493	0.998695237800947	0.326281182839171
down	WNT7A; TGFB2; VANGL2;	GO:0048103~somatic stem cell division	3	9	33.3333333333333	0.00282922229706672	0.0378569615975962	1	1	0.945313379448493	0.998695237800947	0.326281182839171
down	MMP14; MMP16; MEGF8;	GO:0097094~craniofacial suture morphogenesis	3	9	33.3333333333333	0.00282922229706672	0.0378569615975962	1	1	0.945313379448493	0.998695237800947	0.326281182839171
down	TBX1; NLGN4Y; PTCHD1; GAD1; SHANK3; NR2E1;	GO:0035176~social behavior	6	51	11.7647058823529	0.00283896750957191	0.0378569615975962	1	1	0.946373114238343	0.998695237800947	0.326281182839171
down	COL4A1; COL5A2; MMP2; COL16A1; PDGFC; SH3BP4;	GO:0071230~cellular response to amino acid stimulus	6	51	11.7647058823529	0.00283896750957191	0.0378569615975962	1	1	0.946373114238343	0.998695237800947	0.326281182839171
down	SH3PXD2B; SIPA1L3; TGFB2; MAB21L1; MAB21L2;	GO:0001654~eye development	5	35	14.2857142857143	0.00297882982729125	0.0390515792126326	1	1	0.956204374560492	0.998695237800947	0.336577340587323
down	VIL1; ITGA2; ITGA3; SOX9; TGFB2;	GO:0010634~positive regulation of epithelial cell migration	5	35	14.2857142857143	0.00297882982729125	0.0390515792126326	1	1	0.956204374560492	0.998695237800947	0.336577340587323
down	TBX3; FOXG1; TGFB2; PROX1; NR2E1;	GO:0045787~positive regulation of cell cycle	5	35	14.2857142857143	0.00297882982729125	0.0390515792126326	1	1	0.956204374560492	0.998695237800947	0.336577340587323
down	TERT; PDGFB; WT1; TGFB2; APLN;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	5	35	14.2857142857143	0.00297882982729125	0.0390515792126326	1	1	0.956204374560492	0.998695237800947	0.336577340587323
down	SNAI2; EDNRA; SOX9; FOXC2;	GO:0014032~neural crest cell development	4	21	19.047619047619	0.00314047063838729	0.0403200093945013	1	1	0.967893006171301	0.998695237800947	0.347509673310912
down	FSTL3; WT1; MDK; DKK3;	GO:0030325~adrenal gland development	4	21	19.047619047619	0.00314047063838729	0.0403200093945013	1	1	0.967893006171301	0.998695237800947	0.347509673310912
down	ITGAV; TGM2; AXL; MFGE8;	GO:0043277~apoptotic cell clearance	4	21	19.047619047619	0.00314047063838729	0.0403200093945013	1	1	0.967893006171301	0.998695237800947	0.347509673310912
down	PLOD2; PLOD3; GALNT2; EOGT; LARGE2; POMGNT1;	GO:0006493~protein O-linked glycosylation	6	53	11.3207547169811	0.00338100795110485	0.0412421225207038	1	1	0.984978879556669	0.998695237800947	0.355457172234015
down	LGALS1; EFNB2; EFNB1; CAV1; EFNB3; PDCD1LG2;	GO:0031295~T cell costimulation	6	53	11.3207547169811	0.00338100795110485	0.0412421225207038	1	1	0.984978879556669	0.998695237800947	0.355457172234015
down	TGFB2; FZD2; VANGL2;	GO:0003149~membranous septum morphogenesis	3	10	30	0.00361051088691067	0.0412421225207038	1	1	0.992798606028865	0.998695237800947	0.355457172234015
down	ITGA3; FSTL3; FSTL1;	GO:0030510~regulation of BMP signaling pathway	3	10	30	0.00361051088691067	0.0412421225207038	1	1	0.992798606028865	0.998695237800947	0.355457172234015
down	SERPINE2; AXL; STX1A;	GO:0032940~secretion by cell	3	10	30	0.00361051088691067	0.0412421225207038	1	1	0.992798606028865	0.998695237800947	0.355457172234015
down	WNT7A; MSX2; AJUBA;	GO:0035313~wound healing, spreading of epidermal cells	3	10	30	0.00361051088691067	0.0412421225207038	1	1	0.992798606028865	0.998695237800947	0.355457172234015
down	MMP14; MMP16; HMGA2;	GO:0035988~chondrocyte proliferation	3	10	30	0.00361051088691067	0.0412421225207038	1	1	0.992798606028865	0.998695237800947	0.355457172234015
down	ONECUT2; HOXD9; HOXD10;	GO:0048935~peripheral nervous system neuron development	3	10	30	0.00361051088691067	0.0412421225207038	1	1	0.992798606028865	0.998695237800947	0.355457172234015
down	LRP4; NLGN2; NLGN4Y;	GO:0097104~postsynaptic membrane assembly	3	10	30	0.00361051088691067	0.0412421225207038	1	1	0.992798606028865	0.998695237800947	0.355457172234015
down	LRP4; NLGN2; NLGN4Y;	GO:0097105~presynaptic membrane assembly	3	10	30	0.00361051088691067	0.0412421225207038	1	1	0.992798606028865	0.998695237800947	0.355457172234015
down	CYP27B1; CIB2; CAV1; JPH2;	GO:0055074~calcium ion homeostasis	4	22	18.1818181818182	0.00363937445653817	0.0414195473863154	1	1	0.99354922663492	0.998695237800947	0.356986359801474
down	WNT7A; GLI2; SOX9; HMGA2; TGFBI;	GO:0002062~chondrocyte differentiation	5	37	13.5135135135135	0.00369751605125757	0.0417752086227537	1	1	0.995312020221343	0.998695237800947	0.360051729129014
down	STX1A; STON2; SYT1; NLGN2; NLGN4Y;	GO:0048488~synaptic vesicle endocytosis	5	37	13.5135135135135	0.00369751605125757	0.0417752086227537	1	1	0.995312020221343	0.998695237800947	0.360051729129014
down	FLRT2; TBX1; EPHB4; TGFB2; FAT4;	GO:0003007~heart morphogenesis	5	38	13.1578947368421	0.00409988819043061	0.0461534514770576	1	1	0.998695237800947	0.998695237800947	0.397786882637746
down	DLL1; CDH2; JAG1; PROX1;	GO:0097150~neuronal stem cell population maintenance	4	23	17.3913043478261	0.0041894011866499	0.0469908645737229	1	1	0.998695237800947	0.998695237800947	0.405004369836251
down	WNT7A; COL4A2; SOX9; DLX1; CAV1; POSTN;	GO:0071560~cellular response to transforming growth factor beta stimulus	6	56	10.7142857142857	0.00433351314577035	0.0484324652658578	1	1	0.998695237800947	0.998695237800947	0.41742922273415
down	TBX1; LHX1; FOXC2;	GO:0048703~embryonic viscerocranium morphogenesis	3	11	27.2727272727273	0.00451100057501785	0.0498778604504643	1	1	0.998695237800947	0.998695237800947	0.429886779563893
down	SOX9; SOX4; SEMA3C;	GO:0060174~limb bud formation	3	11	27.2727272727273	0.00451100057501785	0.0498778604504643	1	1	0.998695237800947	0.998695237800947	0.429886779563893
down	LAMA5; TGM2; LAMA1;	GO:0060445~branching involved in salivary gland morphogenesis	3	11	27.2727272727273	0.00451100057501785	0.0498778604504643	1	1	0.998695237800947	0.998695237800947	0.429886779563893
down	ONECUT2; SOX9; SOX4; FOXA2;	GO:0031018~endocrine pancreas development	4	24	16.6666666666667	0.00479287384366012	0.0526199965803957	1	1	0.998695237800947	0.998695237800947	0.453520673627828
down	PDGFB; PDGFA; VEGFC; PDGFC;	GO:0031954~positive regulation of protein autophosphorylation	4	24	16.6666666666667	0.00479287384366012	0.0526199965803957	1	1	0.998695237800947	0.998695237800947	0.453520673627828
down	PDGFA; DIXDC1; FSCN1; CELSR1; VANGL2; RHOBTB1; RAC3;	GO:0032956~regulation of actin cytoskeleton organization	7	77	9.09090909090909	0.00490594369464425	0.0536717149973933	1	1	0.998695237800947	0.998695237800947	0.462585213269422
down	PTPRG; IL31RA; AXL; BCAR1; FLT4; EPHB4; DDR1; IGF1R; SHC4;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	9	120	7.5	0.00499751330660025	0.0544816626091473	1	1	0.998695237800947	0.998695237800947	0.469565981235165
down	HMGA2; PKD2; DAB2IP; GATA6;	GO:0071158~positive regulation of cell cycle arrest	4	25	16	0.0054520427628364	0.0580086658490739	1	1	0.998695237800947	0.998695237800947	0.499964479699815
down	PTPRF; FLRT3; NTNG1; GPC4;	GO:0099560~synaptic membrane adhesion	4	25	16	0.0054520427628364	0.0580086658490739	1	1	0.998695237800947	0.998695237800947	0.499964479699815
down	F3; ITGA2; CDH13;	GO:0050927~positive regulation of positive chemotaxis	3	12	25	0.00553557132000848	0.0580086658490739	1	1	0.998695237800947	0.998695237800947	0.499964479699815
down	TBX1; MSX2; FAM20C;	GO:0070166~enamel mineralization	3	12	25	0.00553557132000848	0.0580086658490739	1	1	0.998695237800947	0.998695237800947	0.499964479699815
down	TFPI2; PKD2; HAS2;	GO:0071498~cellular response to fluid shear stress	3	12	25	0.00553557132000848	0.0580086658490739	1	1	0.998695237800947	0.998695237800947	0.499964479699815
down	KCNQ1; HSPG2; SPEG;	GO:0072358~cardiovascular system development	3	12	25	0.00553557132000848	0.0580086658490739	1	1	0.998695237800947	0.998695237800947	0.499964479699815
down	FLRT2; FGF5; ANOS1; FAT4; SPRED2; SPRED1; FLRT3;	GO:0008543~fibroblast growth factor receptor signaling pathway	7	79	8.86075949367089	0.00557876481706121	0.0580086658490739	1	1	0.998695237800947	0.998695237800947	0.499964479699815
down	DIRAS1; PDGFB; PDGFA; AJUBA; MAGED1; PDGFC;	GO:0043406~positive regulation of MAP kinase activity	6	60	10	0.00589392715561332	0.0581347037221924	1	1	0.998695237800947	0.998695237800947	0.501050773596318
down	NKX2-8; SOX9; TGFB2; DAB2IP; MAGED1; DUSP10;	GO:0050680~negative regulation of epithelial cell proliferation	6	60	10	0.00589392715561332	0.0581347037221924	1	1	0.998695237800947	0.998695237800947	0.501050773596318
down	TGFB1I1; MDK; TGFB2; PDPN; LOXL2;	GO:0010718~positive regulation of epithelial to mesenchymal transition	5	42	11.9047619047619	0.00602429877143029	0.0592325831735251	1	1	0.998695237800947	0.998695237800947	0.510513165475607
down	CYP27B1; SLIT3; SERPINE2; INHBA; WT1; CDKN1A; TGFB2; DCBLD2; SH3BP4;	GO:0030308~negative regulation of cell growth	9	124	7.25806451612903	0.00608473511649033	0.0596380820408058	1	1	0.998695237800947	0.998695237800947	0.514008074852188
down	WNT7A; STX1A; NLGN2; SHANK3;	GO:2000463~positive regulation of excitatory postsynaptic potential	4	26	15.3846153846154	0.00616908096705071	0.060274636995681	1	1	0.998695237800947	0.998695237800947	0.51949440800873
down	VWC2L; SOCS2; GLI2; ETV5; FOXG1; NRCAM; NAP1L2;	GO:0045666~positive regulation of neuron differentiation	7	81	8.64197530864197	0.00631833060599318	0.0615393517016327	1	1	0.998695237800947	0.998695237800947	0.530394717827524
down	TBX3; TBX1; ANTXR1; SPHK1; EGFL7;	GO:0001568~blood vessel development	5	43	11.6279069767442	0.00659003933119107	0.0637460111978143	1	1	0.998695237800947	0.998695237800947	0.549413451506964
down	MCAM; TBC1D8B; SULF1;	GO:0003094~glomerular filtration	3	13	23.0769230769231	0.00668850970405133	0.0637460111978143	1	1	0.998695237800947	0.998695237800947	0.549413451506964
down	MDK; CDH3; HAS2;	GO:0010838~positive regulation of keratinocyte proliferation	3	13	23.0769230769231	0.00668850970405133	0.0637460111978143	1	1	0.998695237800947	0.998695237800947	0.549413451506964
down	VIL1; PFN2; SYNPO;	GO:0032233~positive regulation of actin filament bundle assembly	3	13	23.0769230769231	0.00668850970405133	0.0637460111978143	1	1	0.998695237800947	0.998695237800947	0.549413451506964
down	FLT4; VEGFC; PGF;	GO:0038084~vascular endothelial growth factor signaling pathway	3	13	23.0769230769231	0.00668850970405133	0.0637460111978143	1	1	0.998695237800947	0.998695237800947	0.549413451506964
down	TBX3; MSX2; DDR1;	GO:0060444~branching involved in mammary gland duct morphogenesis	3	13	23.0769230769231	0.00668850970405133	0.0637460111978143	1	1	0.998695237800947	0.998695237800947	0.549413451506964
down	TERT; SERPINE1; CDKN1A;	GO:0090399~replicative senescence	3	13	23.0769230769231	0.00668850970405133	0.0637460111978143	1	1	0.998695237800947	0.998695237800947	0.549413451506964
down	WNT7A; CYP27B1; KRT19; MMP14; CAV1; GATA6;	GO:0043627~response to estrogen	6	62	9.67741935483871	0.00681153047193273	0.0647199546675687	1	1	0.998695237800947	0.998695237800947	0.55780766525047
down	NRP1; FLT4; DAB2IP; SPHK1;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	4	27	14.8148148148148	0.00694608009848707	0.0648092218198178	1	1	0.998695237800947	0.998695237800947	0.558577040044309
down	TBX1; CPS1; LHX1; POSTN;	GO:0044344~cellular response to fibroblast growth factor stimulus	4	27	14.8148148148148	0.00694608009848707	0.0648092218198178	1	1	0.998695237800947	0.998695237800947	0.558577040044309
down	SERPINE2; GLI2; MEGF8; GLIS2;	GO:0045879~negative regulation of smoothened signaling pathway	4	27	14.8148148148148	0.00694608009848707	0.0648092218198178	1	1	0.998695237800947	0.998695237800947	0.558577040044309
down	ITGA2; PTPRK; FERMT2; AJUBA;	GO:0048041~focal adhesion assembly	4	27	14.8148148148148	0.00694608009848707	0.0648092218198178	1	1	0.998695237800947	0.998695237800947	0.558577040044309
down	SEMA7A; ITGB1; MAP1B; LHX2;	GO:0048675~axon extension	4	27	14.8148148148148	0.00694608009848707	0.0648092218198178	1	1	0.998695237800947	0.998695237800947	0.558577040044309
down	PTK7; MEGF8; ADAMTS6; APLN;	GO:0060976~coronary vasculature development	4	27	14.8148148148148	0.00694608009848707	0.0648092218198178	1	1	0.998695237800947	0.998695237800947	0.558577040044309
down	AGRN; SDC3; GPC4; APOA4; GPC1; HSPG2;	GO:0001523~retinoid metabolic process	6	63	9.52380952380952	0.00730718348722137	0.0677714002829755	1	1	0.998695237800947	0.998695237800947	0.584107432657782
down	DLL1; TBX2; PKD2; VANGL2; TBX1; TBX3;	GO:0001947~heart looping	6	63	9.52380952380952	0.00730718348722137	0.0677714002829755	1	1	0.998695237800947	0.998695237800947	0.584107432657782
down	WNT7A; TBX3; MSX2; ALX4;	GO:0035116~embryonic hindlimb morphogenesis	4	28	14.2857142857143	0.00778504688000003	0.0716265405738792	1	1	0.998695237800947	0.998695237800947	0.617334075289527
down	CELSR1; VANGL2; PTK7;	GO:0001736~establishment of planar polarity	3	14	21.4285714285714	0.0079735421932472	0.0716265405738792	1	1	0.998695237800947	0.998695237800947	0.617334075289527
down	EXT1; XYLT2; VANGL2;	GO:0015012~heparan sulfate proteoglycan biosynthetic process	3	14	21.4285714285714	0.0079735421932472	0.0716265405738792	1	1	0.998695237800947	0.998695237800947	0.617334075289527
down	VEGFC; ARTN; PGF;	GO:0050930~induction of positive chemotaxis	3	14	21.4285714285714	0.0079735421932472	0.0716265405738792	1	1	0.998695237800947	0.998695237800947	0.617334075289527
down	CDH2; BVES; POPDC3;	GO:0051146~striated muscle cell differentiation	3	14	21.4285714285714	0.0079735421932472	0.0716265405738792	1	1	0.998695237800947	0.998695237800947	0.617334075289527
down	UGT1A6; UGT1A4; UGT1A3;	GO:0052695~cellular glucuronidation	3	14	21.4285714285714	0.0079735421932472	0.0716265405738792	1	1	0.998695237800947	0.998695237800947	0.617334075289527
down	TGFB2; TENM4; FOXC2;	GO:0060038~cardiac muscle cell proliferation	3	14	21.4285714285714	0.0079735421932472	0.0716265405738792	1	1	0.998695237800947	0.998695237800947	0.617334075289527
down	DISP2; GLI2; EVC; DZIP1; PTCHD1; DISP3;	GO:0007224~smoothened signaling pathway	6	65	9.23076923076923	0.00837572672436115	0.0716265405738792	1	1	0.998695237800947	0.998695237800947	0.617334075289527
down	MMP2; VAV2; EFNB2; EPHB4; EFNB1; EFNB3; ARHGEF28;	GO:0048013~ephrin receptor signaling pathway	7	86	8.13953488372093	0.00848456546732723	0.0716265405738792	1	1	0.998695237800947	0.998695237800947	0.617334075289527
down	DLL1; TCF15; FOXC2; SEMA3C; HES7;	GO:0001756~somitogenesis	5	46	10.8695652173913	0.00850875376804727	0.0716265405738792	1	1	0.998695237800947	0.998695237800947	0.617334075289527
down	TBX3; TBX1; TBX2; FZD2; SIX1;	GO:0003151~outflow tract morphogenesis	5	46	10.8695652173913	0.00850875376804727	0.0716265405738792	1	1	0.998695237800947	0.998695237800947	0.617334075289527
down	APP; AGRN; LAMC2; EGFLAM; MAP1B;	GO:0016358~dendrite development	5	46	10.8695652173913	0.00850875376804727	0.0716265405738792	1	1	0.998695237800947	0.998695237800947	0.617334075289527
down	SOCS2; PLOD3; SLIT3; PGF; IGFBP7;	GO:0032870~cellular response to hormone stimulus	5	46	10.8695652173913	0.00850875376804727	0.0716265405738792	1	1	0.998695237800947	0.998695237800947	0.617334075289527
down	NRP1; PDGFB; PGF; VEGFC; PLXNB3;	GO:0050918~positive chemotaxis	5	46	10.8695652173913	0.00850875376804727	0.0716265405738792	1	1	0.998695237800947	0.998695237800947	0.617334075289527
down	SH3PXD2B; SPARC; NPR2; SULF1; PDGFC;	GO:0060348~bone development	5	46	10.8695652173913	0.00850875376804727	0.0716265405738792	1	1	0.998695237800947	0.998695237800947	0.617334075289527
down	HOXC11; HOXA11; GDNF; FOXC2;	GO:0001656~metanephros development	4	29	13.7931034482759	0.0086879000729092	0.0717907061875769	1	1	0.998695237800947	0.998695237800947	0.618748984155911
down	PLOD3; PKD2; PROX1; SEMA3C;	GO:0021915~neural tube development	4	29	13.7931034482759	0.0086879000729092	0.0717907061875769	1	1	0.998695237800947	0.998695237800947	0.618748984155911
down	ITGB1; ITGAV; ITGA2; ITGB6; AXL; EFNB2; EFNB3;	GO:0046718~viral entry into host cell	7	87	8.04597701149425	0.00897606335824919	0.0739751428490192	1	1	0.998695237800947	0.998695237800947	0.637576183900803
down	APP; ITGB1; RAG1; SYNPO; LRRN4;	GO:0008542~visual learning	5	47	10.6382978723404	0.00922584062992937	0.0756324190954896	1	1	0.998695237800947	0.998695237800947	0.65185989900022
down	ABCC9; SLC4A3; KCNQ1; KCNJ12; KCNIP3;	GO:0061337~cardiac conduction	5	47	10.6382978723404	0.00922584062992937	0.0756324190954896	1	1	0.998695237800947	0.998695237800947	0.65185989900022
down	FADS1; FADS2; FADS3;	GO:0006636~unsaturated fatty acid biosynthetic process	3	15	20	0.00939386694615751	0.0766056288758829	1	1	0.998695237800947	0.998695237800947	0.66024778922957
down	THBS1; SPRED1; CARD10;	GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis	3	15	20	0.00939386694615751	0.0766056288758829	1	1	0.998695237800947	0.998695237800947	0.66024778922957
down	TGFB2; PDPN; CDH2; CDH13; CDH3; CDH11; CDH10;	GO:0000902~cell morphogenesis	7	88	7.95454545454545	0.00948809612226931	0.0771715043243213	1	1	0.998695237800947	0.998695237800947	0.665124950598692
down	APOD; LGALS1; MORN4; FLRT3;	GO:0048678~response to axon injury	4	30	13.3333333333333	0.00965646789866104	0.0781318900029683	1	1	0.998695237800947	0.998695237800947	0.67340231259466
down	AGRN; NRP1; FSCN1; TENM2;	GO:0051491~positive regulation of filopodium assembly	4	30	13.3333333333333	0.00965646789866104	0.0781318900029683	1	1	0.998695237800947	0.998695237800947	0.67340231259466
down	ENC1; MDK; ITGA3; PTK7; DAB2IP; FEZ1; TENM3; PLXNB3;	GO:0010976~positive regulation of neuron projection development	8	111	7.20720720720721	0.00978856802359851	0.0789950151930404	1	1	0.998695237800947	0.998695237800947	0.680841406913653
down	TBX1; GLI2; LHX1; SIX1;	GO:0007389~pattern specification process	4	31	12.9032258064516	0.0106924858944846	0.0854024516045336	1	1	0.998695237800947	0.998695237800947	0.73606575253154
down	CPS1; HAAO; SLC39A13; SLC30A3;	GO:0010043~response to zinc ion	4	31	12.9032258064516	0.0106924858944846	0.0854024516045336	1	1	0.998695237800947	0.998695237800947	0.73606575253154
down	NRP1; CDH13; LOXL2; TGFB1I1;	GO:0043542~endothelial cell migration	4	31	12.9032258064516	0.0106924858944846	0.0854024516045336	1	1	0.998695237800947	0.998695237800947	0.73606575253154
down	HOXC6; PAX7; DLX1; SULF1;	GO:0048706~embryonic skeletal system development	4	31	12.9032258064516	0.0106924858944846	0.0854024516045336	1	1	0.998695237800947	0.998695237800947	0.73606575253154
down	WNT9A; TBX1; TNC; SOX9; PTK7; TEAD2;	GO:0071300~cellular response to retinoic acid	6	69	8.69565217391304	0.0108411941466346	0.0857139455660315	1	1	0.998695237800947	0.998695237800947	0.738750453413908
down	MDK; PROX1; NR2E1;	GO:0021542~dentate gyrus development	3	16	18.75	0.0109521842258495	0.0857139455660315	1	1	0.998695237800947	0.998695237800947	0.738750453413908
down	NRP1; VIL1; BCAR1;	GO:0035729~cellular response to hepatocyte growth factor stimulus	3	16	18.75	0.0109521842258495	0.0857139455660315	1	1	0.998695237800947	0.998695237800947	0.738750453413908
down	CD151; DDR1; PDPN;	GO:0044319~wound healing, spreading of cells	3	16	18.75	0.0109521842258495	0.0857139455660315	1	1	0.998695237800947	0.998695237800947	0.738750453413908
down	MDK; HAS2; NCOR2;	GO:0044849~estrous cycle	3	16	18.75	0.0109521842258495	0.0857139455660315	1	1	0.998695237800947	0.998695237800947	0.738750453413908
down	GLI2; TGFB2; FOXF2;	GO:0048566~embryonic digestive tract development	3	16	18.75	0.0109521842258495	0.0857139455660315	1	1	0.998695237800947	0.998695237800947	0.738750453413908
down	DLL1; SIX1; DMRTA2;	GO:0048665~neuron fate specification	3	16	18.75	0.0109521842258495	0.0857139455660315	1	1	0.998695237800947	0.998695237800947	0.738750453413908
down	DBN1; CSMD3; MARK1;	GO:0050773~regulation of dendrite development	3	16	18.75	0.0109521842258495	0.0857139455660315	1	1	0.998695237800947	0.998695237800947	0.738750453413908
down	WNT7A; WNT9A; FZD2; DIXDC1; PYGO1; TCF7L1;	GO:0060070~canonical Wnt signaling pathway	6	70	8.57142857142857	0.0115299367293791	0.0880424362078651	1	1	0.998695237800947	0.998695237800947	0.758819224091363
down	DLL1; TGFB2; JAG1; JAG2; BMP2KL;	GO:0045747~positive regulation of Notch signaling pathway	5	50	10	0.0116244830183001	0.0880424362078651	1	1	0.998695237800947	0.998695237800947	0.758819224091363
down	FADS1; TNFRSF21; G0S2; CYP4A11; FHL2; NCOR2; PSAPL1;	GO:0019216~regulation of lipid metabolic process	7	92	7.60869565217391	0.0117510361536076	0.0880424362078651	1	1	0.998695237800947	0.998695237800947	0.758819224091363
down	DLL1; NEFL; SOX4; PKD2;	GO:0021510~spinal cord development	4	32	12.5	0.0117975951738607	0.0880424362078651	1	1	0.998695237800947	0.998695237800947	0.758819224091363
down	DLL1; JAG1; PROX1;	GO:0001709~cell fate determination	3	17	17.6470588235294	0.0126507254695811	0.09270236800469	1	1	0.998695237800947	0.998695237800947	0.798982195298076
down	LAMA1; TCF15; PTK7;	GO:0045198~establishment of epithelial cell apical/basal polarity	3	17	17.6470588235294	0.0126507254695811	0.09270236800469	1	1	0.998695237800947	0.998695237800947	0.798982195298076
down	PDGFB; THBS1; CCL26;	GO:0050921~positive regulation of chemotaxis	3	17	17.6470588235294	0.0126507254695811	0.09270236800469	1	1	0.998695237800947	0.998695237800947	0.798982195298076
down	BMP1; MDK; SOX9;	GO:0061036~positive regulation of cartilage development	3	17	17.6470588235294	0.0126507254695811	0.09270236800469	1	1	0.998695237800947	0.998695237800947	0.798982195298076
down	SNAI2; ITGB1; CAV1;	GO:2000811~negative regulation of anoikis	3	17	17.6470588235294	0.0126507254695811	0.09270236800469	1	1	0.998695237800947	0.998695237800947	0.798982195298076
down	SIPA1L3; PLEKHG5; RHOBTB1; VAV2; RAC3; FGD1; ARHGAP29; SYDE1; ARHGAP22;	GO:0051056~regulation of small GTPase mediated signal transduction	9	141	6.38297872340426	0.0128452600848419	0.0939064072555382	1	1	0.998695237800947	0.998695237800947	0.809359556141966
down	TERT; PDGFB; MMP2; ADAMTS1;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	4	33	12.1212121212121	0.0129733410642187	0.0946201189824586	1	1	0.998695237800947	0.998695237800947	0.815510887274694
down	COL4A1; TNC; COL4A5; AGRN;	GO:0007528~neuromuscular junction development	4	34	11.7647058823529	0.0142211720970898	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	SOX9; SIX1; SIX4; PYGO1;	GO:0034504~protein localization to nucleus	4	34	11.7647058823529	0.0142211720970898	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	MMP2; TPM1; PKD2; PTPRK;	GO:0034614~cellular response to reactive oxygen species	4	34	11.7647058823529	0.0142211720970898	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	FAT1; PARVA; RAC3; RHOBTB1; FSCN1;	GO:0007163~establishment or maintenance of cell polarity	5	53	9.43396226415094	0.0144150838670909	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	SOX9; TGFB2; TBX2;	GO:0003203~endocardial cushion morphogenesis	3	18	16.6666666666667	0.0144912810675515	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	SPRED2; SPRED1; SPRED3;	GO:0010801~negative regulation of peptidyl-threonine phosphorylation	3	18	16.6666666666667	0.0144912810675515	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	GLI2; EN2; GBX2;	GO:0030902~hindbrain development	3	18	16.6666666666667	0.0144912810675515	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	NRP1; SEMA4F; NRCAM;	GO:0031290~retinal ganglion cell axon guidance	3	18	16.6666666666667	0.0144912810675515	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	LGALS1; MAPK12; JAG1;	GO:0045445~myoblast differentiation	3	18	16.6666666666667	0.0144912810675515	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	GJC1; TBX2; GATA5;	GO:0048738~cardiac muscle tissue development	3	18	16.6666666666667	0.0144912810675515	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	SYT1; GRIK2; CLSTN1;	GO:0050806~positive regulation of synaptic transmission	3	18	16.6666666666667	0.0144912810675515	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	APOD; THBS1; MMP14;	GO:0051895~negative regulation of focal adhesion assembly	3	18	16.6666666666667	0.0144912810675515	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	TBX1; SIX1; SIX4;	GO:0060037~pharyngeal system development	3	18	16.6666666666667	0.0144912810675515	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	TPM1; CDKN1A; APLN;	GO:1904706~negative regulation of vascular smooth muscle cell proliferation	3	18	16.6666666666667	0.0144912810675515	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	BCAR1; FAT1; DBN1; FHOD3; TPM1; CORO6; RHOBTB1; RAC3;	GO:0007015~actin filament organization	8	121	6.61157024793388	0.0153740377576739	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	APP; WT1; CPS1; KCNQ1; PKD2;	GO:0071320~cellular response to cAMP	5	54	9.25925925925926	0.0154367575630353	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	NKX2-8; ONECUT2; PKD2; PCSK9; PROX1; GATA6;	GO:0001889~liver development	6	75	8	0.0154404856257043	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	PDPN; SLC7A5; SLC38A7; SLC38A5;	GO:0003333~amino acid transmembrane transport	4	35	11.4285714285714	0.0155424393234407	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	WNT7A; KIF26B; BRSK1; FEZ1;	GO:0030010~establishment of cell polarity	4	35	11.4285714285714	0.0155424393234407	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	TERT; SNAI2; CSF2; GDNF;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	4	35	11.4285714285714	0.0155424393234407	0.102073812236499	1	1	0.998695237800947	0.998695237800947	0.879752700373694
down	THBS1; JAG1; POSTN;	GO:0001953~negative regulation of cell-matrix adhesion	3	19	15.7894736842105	0.016475226900573	0.1059803933335	1	1	0.998695237800947	0.998695237800947	0.913422700484514
down	LRP4; MDK; SOX9;	GO:0030279~negative regulation of ossification	3	19	15.7894736842105	0.016475226900573	0.1059803933335	1	1	0.998695237800947	0.998695237800947	0.913422700484514
down	TBX3; WT1; HOXD13;	GO:0030539~male genitalia development	3	19	15.7894736842105	0.016475226900573	0.1059803933335	1	1	0.998695237800947	0.998695237800947	0.913422700484514
down	PFN2; FHOD3; KANK4;	GO:0030837~negative regulation of actin filament polymerization	3	19	15.7894736842105	0.016475226900573	0.1059803933335	1	1	0.998695237800947	0.998695237800947	0.913422700484514
down	ITGB1; ITGAV; ITGA2;	GO:0031589~cell-substrate adhesion	3	19	15.7894736842105	0.016475226900573	0.1059803933335	1	1	0.998695237800947	0.998695237800947	0.913422700484514
down	HOXA11; SOX9; LOXL2;	GO:0032332~positive regulation of chondrocyte differentiation	3	19	15.7894736842105	0.016475226900573	0.1059803933335	1	1	0.998695237800947	0.998695237800947	0.913422700484514
down	TCF15; HES7; VANGL2;	GO:0036342~post-anal tail morphogenesis	3	19	15.7894736842105	0.016475226900573	0.1059803933335	1	1	0.998695237800947	0.998695237800947	0.913422700484514
down	LAMA5; LAMA1; LAMA3;	GO:0045995~regulation of embryonic development	3	19	15.7894736842105	0.016475226900573	0.1059803933335	1	1	0.998695237800947	0.998695237800947	0.913422700484514
down	PDGFA; APP; PDGFC;	GO:0050730~regulation of peptidyl-tyrosine phosphorylation	3	19	15.7894736842105	0.016475226900573	0.1059803933335	1	1	0.998695237800947	0.998695237800947	0.913422700484514
down	WNT9A; GDNF; DLX1; DLX2;	GO:0045597~positive regulation of cell differentiation	4	36	11.1111111111111	0.0169383959339682	0.108734702824048	1	1	0.998695237800947	0.998695237800947	0.937161514181022
down	TNFRSF21; THBS1; AKAP12; POSTN; DAB2IP; HAS2; ADAMTS7; CCL26;	GO:0071356~cellular response to tumor necrosis factor	8	125	6.4	0.0181523641200882	0.116048138520811	1	1	0.998695237800947	0.998695237800947	1
down	WT1; LHX1; SIX1; FOXC2;	GO:0001657~ureteric bud development	4	37	10.8108108108108	0.0184101971602362	0.117006536178151	1	1	0.998695237800947	0.998695237800947	1
down	WNT7A; BMP1; SOX9;	GO:0001502~cartilage condensation	3	20	15	0.018603549685229	0.117006536178151	1	1	0.998695237800947	0.998695237800947	1
down	PDGFB; CSF2; PKD2;	GO:0001892~embryonic placenta development	3	20	15	0.018603549685229	0.117006536178151	1	1	0.998695237800947	0.998695237800947	1
down	CDKN1A; HMGA2; BRSK1;	GO:0007095~mitotic G2 DNA damage checkpoint	3	20	15	0.018603549685229	0.117006536178151	1	1	0.998695237800947	0.998695237800947	1
down	NRP1; TNFRSF21; NRCAM;	GO:0007413~axonal fasciculation	3	20	15	0.018603549685229	0.117006536178151	1	1	0.998695237800947	0.998695237800947	1
down	PDGFA; RAC3; PARVA;	GO:0030031~cell projection assembly	3	20	15	0.018603549685229	0.117006536178151	1	1	0.998695237800947	0.998695237800947	1
down	APP; GRIK2; SYNPO;	GO:0048169~regulation of long-term neuronal synaptic plasticity	3	20	15	0.018603549685229	0.117006536178151	1	1	0.998695237800947	0.998695237800947	1
down	WNT7A; ARHGAP22; NRCAM;	GO:0099175~regulation of postsynapse organization	3	20	15	0.018603549685229	0.117006536178151	1	1	0.998695237800947	0.998695237800947	1
down	THBS1; TNC; MAP1B; MMP14; POSTN;	GO:0009612~response to mechanical stimulus	5	57	8.7719298245614	0.0187882173800883	0.1172188582328	1	1	0.998695237800947	0.998695237800947	1
down	IGF1R; NCS1; MUC5AC; PLCB4; PLCH2;	GO:0048015~phosphatidylinositol-mediated signaling	5	57	8.7719298245614	0.0187882173800883	0.1172188582328	1	1	0.998695237800947	0.998695237800947	1
down	PDGFB; THBS1; ITGA2; TGM2; CDH13;	GO:0048661~positive regulation of smooth muscle cell proliferation	5	57	8.7719298245614	0.0187882173800883	0.1172188582328	1	1	0.998695237800947	0.998695237800947	1
down	THBS1; SPARC; TRPC1; CAV1; KCNMA1;	GO:0051592~response to calcium ion	5	57	8.7719298245614	0.0187882173800883	0.1172188582328	1	1	0.998695237800947	0.998695237800947	1
down	PLOD2; CYP27B1; FADS1; PLOD3; FADS2; LIPF; P4HA1; VCAM1; CYP4A11; AOX1; CYP24A1; DHRS2; PTGIS; CYP27C1; MICAL3; P3H3; MSRB3; CYP4Z2P; GPX8; PXDN; FADS3; STEAP2;	GO:0055114~oxidation-reduction process	22	526	4.18250950570342	0.0198489105260889	0.118118673621656	1	1	0.998695237800947	0.998695237800947	1
down	WNT7A; SOCS2; NR2F2; MAP1B; STXBP1; POSTN; NCOR2;	GO:0032355~response to estradiol	7	103	6.79611650485437	0.019946988887048	0.118118673621656	1	1	0.998695237800947	0.998695237800947	1
down	INHBA; MMP14; FOXL2; MMP19;	GO:0001541~ovarian follicle development	4	38	10.5263157894737	0.0199589004349434	0.118118673621656	1	1	0.998695237800947	0.998695237800947	1
down	KCNQ1; CAV1; DSG2; SCN4B;	GO:0086091~regulation of heart rate by cardiac conduction	4	38	10.5263157894737	0.0199589004349434	0.118118673621656	1	1	0.998695237800947	0.998695237800947	1
down	NRP1; MDK; RAC3; HAS2;	GO:1900026~positive regulation of substrate adhesion-dependent cell spreading	4	38	10.5263157894737	0.0199589004349434	0.118118673621656	1	1	0.998695237800947	0.998695237800947	1
down	APP; THBS1; AKAP12;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	3	21	14.2857142857143	0.0208768711726074	0.122617086452346	1	1	0.998695237800947	0.998695237800947	1
down	LMX1B; DMRTA2; FOXA2;	GO:0071542~dopaminergic neuron differentiation	3	21	14.2857142857143	0.0208768711726074	0.122617086452346	1	1	0.998695237800947	0.998695237800947	1
down	SH3PXD2B; STX1A; FERMT2;	GO:0072657~protein localization to membrane	3	21	14.2857142857143	0.0208768711726074	0.122617086452346	1	1	0.998695237800947	0.998695237800947	1
down	NLGN2; SHANK3; SHISA9;	GO:2000311~regulation of AMPA receptor activity	3	21	14.2857142857143	0.0208768711726074	0.122617086452346	1	1	0.998695237800947	0.998695237800947	1
down	PLCH2; APOA4; LIPF; PLCB4; LIPN; LIPM;	GO:0016042~lipid catabolic process	6	81	7.40740740740741	0.0212400307955632	0.12421606793739	1	1	0.998695237800947	0.998695237800947	1
down	DLL1; TBX1; PKD2; DNAH5; BICC1;	GO:0007368~determination of left/right symmetry	5	59	8.47457627118644	0.0212690531518157	0.12421606793739	1	1	0.998695237800947	0.998695237800947	1
down	PDGFB; THBS1; SPARC; MAP1B; FEZ1;	GO:0071363~cellular response to growth factor stimulus	5	59	8.47457627118644	0.0212690531518157	0.12421606793739	1	1	0.998695237800947	0.998695237800947	1
down	PDGFB; THBS1; VEGFC; AMOTL1;	GO:0043536~positive regulation of blood vessel endothelial cell migration	4	39	10.2564102564103	0.0215854657933401	0.125827471331909	1	1	0.998695237800947	0.998695237800947	1
down	MMP2; DDR1; IGFBP7; PTGIS;	GO:0007566~embryo implantation	4	40	10	0.0232907564960785	0.133416701563572	1	1	0.998695237800947	0.998695237800947	1
down	TNFRSF21; APP; GRIK2; SCN2A;	GO:0051402~neuron apoptotic process	4	40	10	0.0232907564960785	0.133416701563572	1	1	0.998695237800947	0.998695237800947	1
down	LHX1; EFNB1; SATB2;	GO:0009880~embryonic pattern specification	3	22	13.6363636363636	0.0232954712454729	0.133416701563572	1	1	0.998695237800947	0.998695237800947	1
down	THBS1; NR2F2; DAB2IP;	GO:0010596~negative regulation of endothelial cell migration	3	22	13.6363636363636	0.0232954712454729	0.133416701563572	1	1	0.998695237800947	0.998695237800947	1
down	APOD; MDK; CDKN1A;	GO:0042246~tissue regeneration	3	22	13.6363636363636	0.0232954712454729	0.133416701563572	1	1	0.998695237800947	0.998695237800947	1
down	FAT1; VANGL2; MTCL1;	GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity	3	22	13.6363636363636	0.0232954712454729	0.133416701563572	1	1	0.998695237800947	0.998695237800947	1
down	SYT1; BVES; STX1A;	GO:0048278~vesicle docking	3	22	13.6363636363636	0.0232954712454729	0.133416701563572	1	1	0.998695237800947	0.998695237800947	1
down	HOXD9; HOXD10; HOXA11; FOXL2; MFGE8;	GO:0007338~single fertilization	5	61	8.19672131147541	0.0239537645109458	0.133416701563572	1	1	0.998695237800947	0.998695237800947	1
down	LGALS1; PTPRG; EFNB2; SPOCK1; CRMP1;	GO:0010977~negative regulation of neuron projection development	5	61	8.19672131147541	0.0239537645109458	0.133416701563572	1	1	0.998695237800947	0.998695237800947	1
down	VEGFC; FOXG1; DMRTA2;	GO:0002052~positive regulation of neuroblast proliferation	3	23	13.0434782608696	0.0258593099570636	0.140955922871222	1	1	0.998695237800947	0.998695237800947	1
down	TBX1; PDGFA; SOX9;	GO:0002053~positive regulation of mesenchymal cell proliferation	3	23	13.0434782608696	0.0258593099570636	0.140955922871222	1	1	0.998695237800947	0.998695237800947	1
down	GRIN3B; APP; GRIK2;	GO:0035235~ionotropic glutamate receptor signaling pathway	3	23	13.0434782608696	0.0258593099570636	0.140955922871222	1	1	0.998695237800947	0.998695237800947	1
down	GLI2; HOXA11; DMBX1;	GO:0048589~developmental growth	3	23	13.0434782608696	0.0258593099570636	0.140955922871222	1	1	0.998695237800947	0.998695237800947	1
down	NRP1; TBX1; FOXC2;	GO:0048844~artery morphogenesis	3	23	13.0434782608696	0.0258593099570636	0.140955922871222	1	1	0.998695237800947	0.998695237800947	1
down	TBX3; CDKN1A; TBX2;	GO:0090398~cellular senescence	3	23	13.0434782608696	0.0258593099570636	0.140955922871222	1	1	0.998695237800947	0.998695237800947	1
down	WNT7A; SOX9; SOX4; VANGL2; NR2E1;	GO:0035019~somatic stem cell population maintenance	5	63	7.93650793650794	0.0268474000870058	0.146085590315809	1	1	0.998695237800947	0.998695237800947	1
down	THBS1; TGFB2; CAV1; DSG2;	GO:0032570~response to progesterone	4	42	9.52380952380952	0.0269404882453252	0.146335833878017	1	1	0.998695237800947	0.998695237800947	1
down	LDOC1; CSF2; SERPINE1; CSF3; AXL; IL24; DAB2IP; PDCD1LG2; IL1F10;	GO:0071222~cellular response to lipopolysaccharide	9	163	5.52147239263804	0.0283508668559244	0.152316660715169	1	1	0.998695237800947	0.998695237800947	1
down	NEFL; DLX1; DLX2; FEZ1; LHX5;	GO:0021766~hippocampus development	5	64	7.8125	0.0283739795087026	0.152316660715169	1	1	0.998695237800947	0.998695237800947	1
down	DLL1; TBX3; SOX9;	GO:0045662~negative regulation of myoblast differentiation	3	24	12.5	0.0285680485532857	0.152316660715169	1	1	0.998695237800947	0.998695237800947	1
down	AXL; CDKN1A; PGF; PTPRU;	GO:0031100~animal organ regeneration	4	43	9.30232558139535	0.0288861802893698	0.152316660715169	1	1	0.998695237800947	0.998695237800947	1
down	SNAI2; VIL1; SOX9; DAB2IP;	GO:0071364~cellular response to epidermal growth factor stimulus	4	43	9.30232558139535	0.0288861802893698	0.152316660715169	1	1	0.998695237800947	0.998695237800947	1
down	TBX1; RAG1; SIX1; SIX4;	GO:0048538~thymus development	4	44	9.09090909090909	0.0309131021949032	0.161132515327977	1	1	0.998695237800947	0.998695237800947	1
down	APP; NEFL; RAC3; NLGN2;	GO:0050885~neuromuscular process controlling balance	4	44	9.09090909090909	0.0309131021949032	0.161132515327977	1	1	0.998695237800947	0.998695237800947	1
down	APP; PTHLH; GDNF; LHX1; SHC4; MEGF8; PROX1; MAPK11; MAPK12;	GO:0010468~regulation of gene expression	9	166	5.42168674698795	0.0311859375554152	0.161631230122432	1	1	0.998695237800947	0.998695237800947	1
down	SOCS2; GPC4; AFAP1;	GO:0009966~regulation of signal transduction	3	25	12	0.0314210695184902	0.161631230122432	1	1	0.998695237800947	0.998695237800947	1
down	SERPINB7; ITGA2; LARP6;	GO:0032967~positive regulation of collagen biosynthetic process	3	25	12	0.0314210695184902	0.161631230122432	1	1	0.998695237800947	0.998695237800947	1
down	UGT1A3; CYP27C1; ADH1A;	GO:0042573~retinoic acid metabolic process	3	25	12	0.0314210695184902	0.161631230122432	1	1	0.998695237800947	0.998695237800947	1
down	TERT; SPARC; HAAO;	GO:0046686~response to cadmium ion	3	25	12	0.0314210695184902	0.161631230122432	1	1	0.998695237800947	0.998695237800947	1
down	TPM1; PROX1; FOXC2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	3	25	12	0.0314210695184902	0.161631230122432	1	1	0.998695237800947	0.998695237800947	1
down	G0S2; CAV1; TNFRSF12A;	GO:2001238~positive regulation of extrinsic apoptotic signaling pathway	3	25	12	0.0314210695184902	0.161631230122432	1	1	0.998695237800947	0.998695237800947	1
down	SPOCK1; FAT4; NAV3; PCSK9;	GO:0022008~neurogenesis	4	45	8.88888888888889	0.0330216492341522	0.169583907719853	1	1	0.998695237800947	0.998695237800947	1
down	DUSP4; DAB2IP; SPRED1; SPRY4; DUSP10;	GO:0070373~negative regulation of ERK1 and ERK2 cascade	5	67	7.46268656716418	0.0332786501729503	0.17062172621676	1	1	0.998695237800947	0.998695237800947	1
down	CHST3; CHPF; XYLT2;	GO:0030206~chondroitin sulfate biosynthetic process	3	26	11.5384615384615	0.0344174956826135	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	TGFB2; DAB2IP; SPRY4;	GO:0046580~negative regulation of Ras protein signal transduction	3	26	11.5384615384615	0.0344174956826135	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	CDH2; MAPK12; MAPK11;	GO:0051149~positive regulation of muscle cell differentiation	3	26	11.5384615384615	0.0344174956826135	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	SRRM4; TBX1; SNAI2; TFAP2A; PAX3; KCNQ1; SIX1; PDZD7;	GO:0007605~sensory perception of sound	8	143	5.59440559440559	0.0351584266006338	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	DAB2IP; RTKN; SH3BP4; PLXNB3;	GO:0034260~negative regulation of GTPase activity	4	46	8.69565217391304	0.0352121273527786	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	TPM1; DMD; KCNQ1; SCN4B;	GO:0060048~cardiac muscle contraction	4	46	8.69565217391304	0.0352121273527786	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	PLAU; SERPINE2; F3; ITGA2; TFPI2; HIST2H3A; GATA6; GATA5; EHD2;	GO:0007596~blood coagulation	9	171	5.26315789473684	0.0363386419025629	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	LAMA5; CDH2; STXBP1; GPR158; TTC7B; EHD2; KCNIP3; RAB3B;	GO:0072659~protein localization to plasma membrane	8	144	5.55555555555556	0.0363390572275312	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	NEFL; CRMP1; MAP6; DOCK7; MARK1; MAP1B; TUBB3;	GO:0000226~microtubule cytoskeleton organization	7	118	5.93220338983051	0.0365810248704241	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	NEFL; CDH2; MDK; LHX2; FAT4;	GO:0021987~cerebral cortex development	5	69	7.2463768115942	0.03682335042911	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	HIC1; NOTUM; APCDD1L; WIF1;	GO:0030178~negative regulation of Wnt signaling pathway	4	47	8.51063829787234	0.0374847548919224	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	FSTL3; DLX1; HTRA1; VWC2L;	GO:0030514~negative regulation of BMP signaling pathway	4	47	8.51063829787234	0.0374847548919224	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	PLCH2; PLCB4; NUDT11; ISYNA1;	GO:0043647~inositol phosphate metabolic process	4	47	8.51063829787234	0.0374847548919224	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	ADGRB2; ARTN; GDNF;	GO:0007422~peripheral nervous system development	3	27	11.1111111111111	0.0375562084287701	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	FN1; THBS1; TGM2;	GO:0018149~peptide cross-linking	3	27	11.1111111111111	0.0375562084287701	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	TEAD2; FAT4; AMOTL1;	GO:0035329~hippo signaling	3	27	11.1111111111111	0.0375562084287701	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	ITGB4; MMP14; FSCN1;	GO:0048870~cell motility	3	27	11.1111111111111	0.0375562084287701	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	PDGFB; THBS1; CDKN1A;	GO:2000379~positive regulation of reactive oxygen species metabolic process	3	27	11.1111111111111	0.0375562084287701	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	THBS1; ITGA2; SOX4; RBMS3; LARP6;	GO:0045727~positive regulation of translation	5	70	7.14285714285714	0.0386792187351386	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	SHANK3; ADRA1D; ADRA1B;	GO:0007610~behavior	3	28	10.7142857142857	0.0408358650356163	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	FLT4; CCBE1; SULF1;	GO:0010575~positive regulation of vascular endothelial growth factor production	3	28	10.7142857142857	0.0408358650356163	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	FAT4; ALX4; PDGFC;	GO:0048565~digestive tract development	3	28	10.7142857142857	0.0408358650356163	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	ITGB1; TGFB2; LTBP2; PTPRK; FERMT2; TGFB1I1;	GO:0007179~transforming growth factor beta receptor signaling pathway	6	96	6.25	0.0417086263494645	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	APP; TUSC3; LCE1D; PTCHD1;	GO:0050890~cognition	4	49	8.16326530612245	0.0422769046196133	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	WNT9A; THBS1; VIL1; RAG1; NAIP;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	5	72	6.94444444444444	0.0425593473890105	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	NCS1; BRSK1; MARK1;	GO:0010975~regulation of neuron projection development	3	29	10.3448275862069	0.0442549151896756	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	VIL1; MICALL2; WASF3;	GO:0030041~actin filament polymerization	3	29	10.3448275862069	0.0442549151896756	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	TGFB1I1; THBS1; FERMT1;	GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway	3	29	10.3448275862069	0.0442549151896756	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	TERT; TCF7L1; PYGO1;	GO:1904837~beta-catenin-TCF complex assembly	3	29	10.3448275862069	0.0442549151896756	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	WNT7A; APP; GPC4;	GO:1905606~regulation of presynapse assembly	3	29	10.3448275862069	0.0442549151896756	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	APP; APOA4; PCSK9; DISP3; LIMA1;	GO:0008203~cholesterol metabolic process	5	73	6.84931506849315	0.0445840362887988	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	FLT4; DDR1; EPHB4; IGF1R; AXL;	GO:0033674~positive regulation of kinase activity	5	73	6.84931506849315	0.0445840362887988	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	VIL1; SOX9; BCAR1; EFEMP1;	GO:0007173~epidermal growth factor receptor signaling pathway	4	50	8	0.0447964423488492	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	ELFN1; ELFN2; SPOCD1; SPRED1;	GO:0010923~negative regulation of phosphatase activity	4	50	8	0.0447964423488492	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	PLOD3; CAV1; TNS4; NRCAM; CCDC68;	GO:0008104~protein localization	5	74	6.75675675675676	0.0466653645770764	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	PTPRF; PTPRG; DUSP4; PTPRK; PTPN14; PTPRU;	GO:0035335~peptidyl-tyrosine dephosphorylation	6	99	6.06060606060606	0.0469070066999311	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	ATP7B; SLC39A13; MT1M;	GO:0006882~cellular zinc ion homeostasis	3	30	10	0.0478116167013932	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	PGA5; PGC; UCN2;	GO:0007586~digestion	3	30	10	0.0478116167013932	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	SYT1; STXBP1; STX1A;	GO:0014047~glutamate secretion	3	30	10	0.0478116167013932	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	CAV1; ADRA1B; ADRA1D;	GO:0045907~positive regulation of vasoconstriction	3	30	10	0.0478116167013932	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	MSX2; HMGA2; SHC4;	GO:0048863~stem cell differentiation	3	30	10	0.0478116167013932	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	SERPINE2; SYT1; CDH2;	GO:0051966~regulation of synaptic transmission, glutamatergic	3	30	10	0.0478116167013932	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
down	TFAP2A; HAS2; PAPPA2;	GO:0060349~bone morphogenesis	3	30	10	0.0478116167013932	0.170759752297085	1	1	0.998695237800947	0.998695237800947	1
